MedTrace Logo

The Role of OCTA in Patients Affected by Beta Thalassemia

NCT04582110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2021-02-03

No results posted yet for this study

Summary

To investigate, using optical coherence tomography angiography (OCTA), the retinal and choriocapillaris vascular features in patients affected by Beta Thalassemia. Moreover we analyzed the structural retinal parameters (ganglion cell complex and retinal nerve fiber layer), using optical coherence tomography (OCT) in these patients

Conditions

Interventions

DIAGNOSTIC_TEST

Optical coherence tomography angiography

Each subject underwent Optical coherence tomography angiography (a non-invasive, fast, diagnostic imaging technique)

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-02-25
Completion
2020-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582110 on ClinicalTrials.gov